Overview / Abstract: |
Target Audience Program Overview This enduring activity is a recorded session from Oncology Congress that took place on September 24, 2022. Learning Objectives Apply biomarker testing results to guide treatment decisions for NSCLC |
Expiration |
Dec 15, 2023 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Eisai, Inc.; Merck Sharp & Dohme, LLC, a subsidiary of Merck & Co., Inc.; and Regeneron Pharmaceuticals, Inc. and Sanofi. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Non-Small Cell Lung Cancer, Lung Cancer Free CE CME |